Our results show that L-4F treatment significantly inhibited tumor progression (Figure 1A–1C), decreased inflammatory cell infiltration in tumor tissues (Figure 3D), and reduced percentages of IL-17A-, IL-6-, GM-CSF- and IL-1β-producing cells to varying degrees in tumor tissues (Figure 3A, 3B). The gene discussed is IL1B; the disease is neoplasm.